Analyst ratings and price targets can significantly influence a company's stock price. In this case, UBS, a reputable financial institution, has initiated coverage on Ceridian HCM Holding with a Buy rating and a price target of $87. This suggests that UBS sees potential in the company, which could encourage investors to buy the stock, potentially driving up its price in the short term.